InflaRx NV (IFRX)
1.015
0.00 (0.00%)
USD |
NASDAQ |
Dec 30, 16:00
0.982
-0.03
(-3.25%)
After-Hours: 20:00
InflaRx Total Assets (Quarterly): 76.56M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CDT Equity, Inc. | 8.552M |
| LENZ Therapeutics, Inc. | 210.70M |
| Liminatus Pharma, Inc. | 1.342M |
| Oruka Therapeutics, Inc. | 509.25M |
| Maze Therapeutics, Inc. | 422.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.25M |
| Shareholders Equity (Quarterly) | 53.31M |
| Debt to Equity Ratio | 0.0214 |
| Current Ratio | 3.331 |
| Net Debt Paydown Yield | 0.01% |